Finding the best steroid dose for ARDS patients on a ventilator
Part of Lungs & breathing clinical trials.
This trial tests different doses of corticosteroids to find the best one for people with acute respiratory distress syndrome (ARDS) who are on a breathing machine. It aims to improve recovery while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ARDS (a serious lung condition) and need extra oxygen (FiO₂ of 50% or more)
- You are on a breathing machine (ventilator) right now
- You have been on the breathing machine for less than 3 days
- You are 18 years or older
- You are not already taking steroids or have a condition that prevents their use
- You do not have uncontrolled internal bleeding or infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to adjust the amount of air given by the ventilator to people with a severe lung injury called ARDS. The goal is to see if a specific breathing strategy can help protect the lungs and improve recovery.
This trial observes the symptoms, treatments, and recovery of patients with acute respiratory distress syndrome (ARDS), a serious lung condition. It aims to learn more about how different types of breathing support affect outcomes.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This trial tests whether the steroid dexamethasone can help people with sepsis who develop acute respiratory distress syndrome (ARDS), a severe lung injury. If you have an infection and need breathing support, this study may help find a better treatment.
This trial looks at how the immune system might cause severe breathing problems (ARDS). It may help doctors understand what happens in the lungs during this condition and find better ways to treat it.
This study tests if adding a type of steroid (glucocorticoid) to standard treatment helps people on a breathing machine recover from severe lung failure (ARDS). It compares different doses to see which works best.
Hear when a new Acute Respiratory Distress Syndrome (ARDS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.